RSV recombinant candidate vaccine G1F/M2 with CpG as an adjuvant prevents vaccine-associated lung inflammation, which may be associated with the appropriate types of immune memory in spleens and lungs

• Main Authors: Na Li (Author), Ling Zhang (Author), Boyang Zheng (Author), Wenjian Li (Author), Jianxun Liu (Author), Huixian Zhang (Author), Ruihong Zeng (Author)
• Format: Book
• Published: Taylor & Francis Group, 2019-11-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Respiratory syncytial virus (RSV) is a major respiratory pathogen in infants. The early formalin-inactivated RSV not only failed to protect infants against infection, but also was associated with enhanced pulmonary inflammatory disease upon natural infection. A safe and effective vaccine should prev...